Detalles de la búsqueda
1.
Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
J Infect Dis
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438123
2.
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 381(25): 2429-2439, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31661198
3.
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 379(17): 1621-1634, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280651
4.
Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.
Am J Respir Crit Care Med
; 188(4): 492-502, 2013 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23306546
5.
A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults.
J Clin Immunol
; 33(8): 1360-75, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24142232
6.
Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5-17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial.
Lancet Infect Dis
; 22(9): 1329-1342, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35753316
7.
Long-term safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults: Results from a phase II randomized controlled trial.
Medicine (Baltimore)
; 97(45): e13120, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30407329
8.
A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults.
Medicine (Baltimore)
; 95(3): e2459, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26817879
9.
Safety and immunogenicity of the M72/AS01E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study.
Tuberculosis (Edinb)
; 100: 118-127, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27553419
10.
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
Clin Infect Dis
; 40(9): 1271-81, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15825029
11.
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
Vaccine
; 33(32): 4025-34, 2015 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072017
12.
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial.
Tuberculosis (Edinb)
; 94(6): 564-78, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25305000
13.
Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy: a phase I/II, randomized trial.
AIDS
; 28(12): 1769-81, 2014 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-24911353
Resultados
1 -
13
de 13
1
Próxima >
>>